Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
669-02-002 ISMRM Abstract

Cerebral Metabolic Stress Links Insulin Resistance, Rather Than Hyperglycemia, to Functional Decline

Primary: Neuro - Other Neurodegeneration
Secondary: Contrast Mechanisms - Susceptibility/QSM
669-02-002 · Neuroimaging Biomarkers Across the Spectrum of Brain Disorders · Thursday, 14 May, 9:25 AM–10:20 AM · Digital Posters Row J
Accepted
Sri Sai L Akkineni1, Dhruv Bhagat1, Lea Bergeot2, Fahad Salman3, Ferdinand Schweser4, Junghun Cho5,6, Rafeeque Bhadelia7, Katherine L Tucker8, Salil Soman 9
1Medical College of Georgia, Augusta, United States of America
2Northeastern University, Boston, United States of America
3University of Buffalo, Buffalo, United States of America
4University at Buffalo, Buffalo, United States of America
5George Washington University, Washington, United States of America
6Biomedical Engineering, George Washington University, Washington, United States of America
7Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America
8University of Massachusetts Lowell, Lowell, United States of America
9UCSF-Radiology, United States of America
Presenting Author: Salil Soman

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 1. Cahn-Weiner DA, Farias ST, Julian L, Harvey DJ, Kramer JH, Reed BR, Mungas D, Wetzel M, Chui H. Cognitive and neuroimaging predictors of instrumental activities of daily living. J Int Neuropsychol Soc. 2007;13(5):747–57. Epub 20070518. doi: 10.1017/S1355617707070853. PubMed PMID: 17521485; PMCID: PMC2877031. [doi] [pmid]
2. 2. Johnson-Frey SH, Newman-Norlund R, Grafton ST. A Distributed Left Hemisphere Network Active During Planning of Everyday Tool Use Skills. Cerebral Cortex. 2005;15(6):681–95. doi: 10.1093/cercor/bhh169. [doi]
3. 3. Deery HA, Liang E, Di Paolo R, Voigt K, Murray G, Siddiqui MN, Egan GF, Moran C, Jamadar SD. The association of regional cerebral blood flow and glucose metabolism in normative ageing and insulin resistance. Scientific Reports. 2024;14(1). doi: 10.1038/s41598-024-65396-4. [doi]
4. 4. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis Model Assessment Is a Reliable Indicator of Insulin Resistance During Follow-up of Patients With Type 2 Diabetes. Diabetes Care. 2001;24(2):362–5. doi: 10.2337/diacare.24.2.362. [doi]
5. 5. Muniyappa R, Quon MJ. Insulin action and insulin resistance in vascular endothelium. Current Opinion in Clinical Nutrition and Metabolic Care. 2007;10(4):523–30. doi: 10.1097/mco.0b013e32819f8ecd. [doi]
6. 6. Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, Häring H-U. Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans. Physiological Reviews. 2016;96(4):1169–209. doi: 10.1152/physrev.00032.2015. [doi]
7. 7. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nature Reviews Neuroscience. 2011;12(12):723–38. doi: 10.1038/nrn3114. [doi]
8. 8. Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature Reviews Endocrinology. 2018;14(10):591–604. doi: 10.1038/s41574-018-0048-7. [doi]
9. 9. De Felice FG, Ferreira ST. Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease. Diabetes. 2014;63(7):2262–72. doi: 10.2337/db13-1954. [doi]
10. 10. Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang H-Y, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nature Reviews Neurology. 2018;14(3):168–81. doi: 10.1038/nrneurol.2017.185. [doi]
11. 11. Yarchoan M, Arnold SE. Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease. Diabetes. 2014;63(7):2253–61. doi: 10.2337/db14-0287. [doi]
12. 12. Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Plymate SR, Fishel MA, Watson GS, Cholerton BA, Duncan GE, Mehta PD, Craft S. Effects of Aerobic Exercise on Mild Cognitive Impairment. Archives of Neurology. 2010;67(1). doi: 10.1001/archneurol.2009.307. [doi]
13. 13. Mattson MP, Arumugam TV. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metabolism. 2018;27(6):1176–99. doi: 10.1016/j.cmet.2018.05.011. [doi]
14. 14. Biessels GJ, Strachan MWJ, Visseren FLJ, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. The Lancet Diabetes & Endocrinology. 2014;2(3):246–55. doi: 10.1016/s2213-8587(13)70088-3. [doi]
15. 15. Tucker KL, Mattei J, Noel SE, Collado BM, Mendez J, Nelson J, Griffith J, Ordovas JM, Falcon LM. The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities. BMC Public Health. 2010;10(1):107. doi: 10.1186/1471-2458-10-107. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/669-02-002